Reportable Diseases
in Kansas
2002 Summary
Kansas Department of Health and Environment Bureau of Epidemiology and Disease Prevention
REPORTABLE
INFECTIOUS DISEASES IN
KANSAS
2002 SUMMARY
December, 2003
Kansas Department of Health and Environment Division of Health Bureau of Epidemiology and Disease Prevention 1000 S.W. Jackson Street, Suite 210 Topeka, Kansas 66612-1274 Telephone (785) 296-2951 Fax (785) 291-3775
Disease Reporting and Public Health Emergencies: Toll-Free Phone 1-877-427-7317 Toll-Free Fax 1-877-427-7318 Website: www.kdhe.state.ks.us NOTES for 2002 Annual summary
This year’s report has been less timely due to staff turn over and the process of
converting the report production from the original software programs to different
programs. This conversion will allow for better compilation of all the components of the
report and will allow for the project to continue in a more streamlined fashion regardless
of the persons involved in it’s production.
The guidelines stated in the introduction are followed for this report i.e. there are no rates
and no graphics that stratify factors for diseases with counts less than 50. Where the
counts are large enough, graphs and charts may present rates. Some graphs and charts
are presented using counts only and not ratess. Small numbers are always of concern in
depicting disease information as it is important to maintain concern for presentation of
potentially individually identifiable data.
This report has provided a foundation for a new approach to this document in the future.
It is our desire to make this report a useful reference document and that will be evident in the upcoming 2003 Reportable Disease Summary. We welcome constructive suggestions and comments to that end.
Thank you for your patience, it is our privilege to serve the citizens of Kansas.
TABLE OF CONTENTS
INTRODUCTION
SECTION I DISEASE SUMMARIES Shaded diseases/conditions have 0 confirmed cases for 2002 and do not have summaries included.
Acquired Immune Deficiency Syndrome (AIDS) ……………………………………………… Amebiasis ………………………………………………………………………………………. Anthrax Botulism Brucellosis Campylobacter infections Chancroid Chlamydia trachomatis genital infection Cholera Cryptosporidiosis Diphtheria Ehrlichiosis Encephalitis, other infectious Diarrhea-causing Eschericia coli Giardiasis Gonorrhea Haemophilus influenzae, invasive disease Hantavirus Pulmonary Syndrome Hemolytic uremic syndrome, postdiarrheal Hepatitis, viral (acute and chronic) Hepatitis A Hepatitis B Hepatitis C Human Immunodeficiency Virus (HIV) Influenza Lead Poisoning - Pediatric Legionellosis Leprosy (Hansen’s disease) Listeriosis Lyme disease Malaria Measles (rubeola) Meningitis, other bacterial Meningococcocal disease Mumps Pertussis (whooping cough) Plague Poliomyelitis Psittacosis Q Fever Rabies, human and animal Rocky Mountain Spotted Fever Rubella, including congenital rubella syndrome Salmonellosis, non-typhi Shigellosis Smallpox Streptococcal invasive disease Syphilis, including congenital syphilis Tetanus Toxic shock syndrome, streptococcal and staphylococcal Trichinosis Tuberculosis Tularemia Typhoid fever Varicella (chickenpox) deaths Viral hemorrhagic fever Yellow fever List of Diseases with no cases reported in 2002
Section II Special Projects Kansas bioterrorism preparedness and smallpox vaccination program West Nile Virus Retrospective Immunization Coverage Survey – 1998-1999 (School Year 2002-2003) Outbreak of Unexplained Respiratory Illness among Football Players Tuberculosis Among US-Born and Foreign-Born Persons – Kansas, 1998-2002 Section III Appendices Kansas Notifiable Disease form List of Reportable Diseases 2002 List of Reportable Diseases 2001 Kansas Map Kansas County Abbreviations Selected Diseases Chart Table 2. Reportable disease cases by year, kansas, 1993-2002 Table 3. Reportable disease cases by county References INTRODUCTION
Purpose and format of this report
This is the eleventh annual summary of reportable diseases by the Kansas Department of Health and Environment (KDHE). The purpose of this report is to provide useful information about notifiable infectious diseases in Kansas for health care providers, public health workers and policy makers.
The report is divided into three sections. Section I presents summaries of 42 reportable diseases or conditions of public health importance in Kansas. Each of the diseases or conditions is presented with a brief overview of the disease or condition, laboratory tests commonly used for diagnosis, and the surveillance case definition. Tables and graphs supplement a summary of the disease in Kansas, including key statistics and trends. Only cases that meet a surveillance definition for a confirmed case and are reported before March 1, 2003 are presented here. Rates have been calculated from the U.S. Census Bureau and National Center for Health Statistics, Bridged 2002 Population Estimates. Rates by demographic characteristics and proportional changes from previous year are reported only then there were more that 50 cases of a disease reported in the state. Whenever possible, information about disease trends for the United States has been included for comparison with Kansas’s trends. If the total number of cases in the state was less than 5, then only limited demographic information is presented due to confidentiality concerns.
Disease incidence of urban and non-urban counties has been included for many diseases. Urban counties are designated based upon population density. The five counties account for 50% of the population and include: Johnson, Wyandotte, Sedgwick, Shawnee, and Douglas. The remaining 100 counties in the state are aggregated into the “non-urban” category.
Data concerning race and ethnicity are collected uniformly for most diseases as follows: American Indian/Alaskan Native (AIAN), Asian/pacific Islander (API), Black- African- American, and White. Also reported for some diseases are rates for Hispanic and non- Hispanic ethnicity.
Section II includes special studies and reports. Section III provides reference documents including the reportable disease statutes, reportable diseases list and form, county abbreviations, county map of Kansas, summary tables of disease counts by county and disease counts of 10-year trend.
Disease reporting in Kansas
Selected dis3ases are reportable by law in Kansas by health care providers, laboratories and hospitals. Reports of infectious diseases are initially sent to local health departments. The local health departments are responsible for any investigation required and for instituting basic public health interventions such as administration of immune globulin to household contacts of a person with Hepatitis A or treatment of sexual contacts of a person with gonorrhea.
Reports are also sent to the Bureau of Epidemiology and Disease Prevention (BEDP) in KDHE where they are reviewed. After reports have been entered into the Kansas integrated electronic disease surveillance system (also known as HAWK), weekly reports are transmitted to the Centers for Disease Control (CDC) and Prevention. There are specific reports required from states and these are accumulated for inclusion in the report published in the Morbidity and Mortality Weekly Report. Finally, CDC sends selected data to the World Health Organization.
HAWK is a central, statewide database of reportable and selected non-reportable diseases and/or conditions. It can be accessed internally and remotely/on-line only by authorized public health officials. To protect restricted, confidential, health and clinical data of individuals, internal security structures are in place. Users can report disease occurrences efficiently, and generate summary statistics and reports that can assist them in evaluating public health efforts in their local areas.
Surveillance for influenza is accomplished through a sentinel site surveillance method. During the 2002-2003 influenza season, the statewide physician-based active surveillance system included 21 sentinel sites including 9 family practices, 4 student health centers, 4 pediatricians, 3 long term care facilities and 1 military installation. To assess the possible amount and location of influenza activity, the number of patients seen with influenza-like illness (ILI), offices and clinics are contacted weekly by telephone starting in October 2002 and continuing through May 2003. These reports include number of persons with ILI by four age groups and total patient visits for all reasons. Ten sentinel sites agreed to continue to report ILI activity during the summer of 2003. State activity is reported to CDC weekly where it becomes part of the national influenza surveillance picture. Based on information submitted by each state to the CDC we are able to see where ILI is circulating thus the sentinel site surveillance plays an important role in monitoring influenza in the country.
In collaboration with the Council of State and Territorial Epidemiologists (CSTE), CDC publishes case definitions for public health surveillance, providing uniform criteria for reporting cases. This uniformity increases the specificity and comparability of diseases reported from different geographic regions. The CDC/CSTE surveillance case definitions combine clinical, laboratory, and epidemiologic criteria. The MMWR document of case definitions can be located on the web at the following address: http://www.cdc.gov/mmwr/preview/mmwrhtml/00047449.htm or using this reference - Case definitions for infectious conditions under public health surveillance. MMWR 1997; 46(no. RR-10).
The usefulness of public health surveillance data depends on its uniformity, simplicity, and timeliness. The case definitions in this report follow the CDC/CSTE surveillance definitions for disease reporting and should not be confused with clinical diagnoses. Use of additional clinical, epidemiologic, and laboratory data may enable a physician to diagnose a disease even though the formal standardized surveillance case definition may not be met.
Interpretation of the data
When interpreting the data in this report, it is important to remember that disease reporting is incomplete and often varies by disease. For example, reporting of AIDS cases is estimated to be 90% complete whereas reporting of Salmonellosis on a national level is estimated to be 2% complete. Absolute numbers are less meaningful than trends when interpreting the data. However, trends can be influenced by changes in case definitions, reporting patterns, and by random fluctuations. It is also important to note that small numbers affect rates and interpretation of rates. Often, artificially high rates can be reported in the presence of small numbers as well as less stable, widely fluctuating trends.
Disease Highlights and trends 2002
STD
From January 1, 2002 to December 31, 2002 there were 39 cases of early syphilis reported. This is a 13 percent (6 case) decrease compared to the 45 cases reported in calendar year 2001. Ten or 26 percent (10/39) of these early syphilis cases can be attributed to a continuing outbreak within Topeka in the first half of 2002. The last reported early syphilis case in Topeka was in August 2002. These cases centered around commercial sex workers and methamphetamine/cocaine usage. Thirteen or 33 percent (13/39) of the early syphilis cases reported in 2002 were from an emerging outbreak in Johnson and Wyandotte Counties. This outbreak has crack (cocaine) usage and commercial sex workers as cofactors. Kansas had no reports of congenital syphilis in 2002.
For the year, 2,701 cases of gonorrhea were reported to the state. This is a 60 case decrease from 2001. These 60 cases represented a two percent decrease compared to last year. This is the second yearly decrease in reported gonorrhea cases in a row. Based on age reporting, young adults continued to have the highest rates of gonococcal infections; 34 percent (930) in the 20-24 age group, and 28 percent (749) by the 15-19 age group. Combined, both groups accounted for 62% (1,679) of all reported morbidity in 2002. Like syphilis, gonorrhea is concentrated in urban areas of the state.
Chlamydia continued to be the most commonly reported disease in Kansas. For the year, 6,758 cases of chlamydia were reported statewide, representing a nine percent (586 case) increase from the previous year. This was the first full year using a new test for chlamydia at the state laboratory. They went from DNA probe technology to amplified technology. The state lab reported 30 percent of all the Chlamydia cases in Kansas in 2002. Much of the nine percent increase can be attributed to the use of the more sensitive test. Reported chlamydia disproportionately affected females in their childbearing years. Forty percent (2,730) of all reported cases occurred in the 20-24 age group. This is followed by the 15-19 age group, which accounted for 37 percent (2,516) of infections. Combined, the 15-24 age group accounted for 77% (5,246) of all chlamydia infections reported in 2002. Over 80 percent of reported cases occurred among females. This gender disparity reflects the focus of chlamydia detection activities in the state which target females.
Racial and ethnic minorities are disproportionately represented among cases of the three major reportable bacterial STDs, mirroring national trends. This may reflect reporting bias (e.g., African-Americans may use public STD clinics more often for health care and be more likely to be screened or reported if positive). Both syphilis and gonorrhea infections are largely confined to the urban areas of the state. At least one case of chlamydia occurred in 94 of the 105 counties in Kansas. These distributions also reflects national trends. The majority of syphilis cases are reported from public STD clinics, whereas chlamydia and gonorrhea infections are reported from private physicians. Nearly 66% of reported bacterial STD reports are from private providers rather than publicly funded STD and family planning clinics.
TB
Kansas reported 89 cases of active tuberculosis (TB) disease in 2002, up from 80 in 2001. In Kansas during 2002, the state's major metropolitan areas again reported the majority of cases of TB. Sedgwick County once again reported the highest number of new cases of active TB disease with 29. Fifty-four (61%) of the state's cases were among males and 35 (39%) were among females. In 2002, eight cases were reported among children under the age of 14, compared to six cases in 2001. Ten cases were reported for the age group 15- 24; forty for the age group 25-44; eighteen for the age group 45-64; and thirteen among individuals over the age of 65. During 2002, there were four reported case of HIV co- infection and two cases of multi- drug resistant TB in the state.
The Kansas Department of Health and Environment dedicated many resources to investigation of an active case of TB diagnosed in one of the state prisons in 2002. The identification of this case uncovered many deficiencies in procedures used in county jails and state prisons. This inmate had been housed in three county jails over eight months prior to placement in the state prison system. Two of these county jails are considered overflow jails receiving a constant flow of multiple inmates from other counties who have maximized their local jail capacity. This inmate was symptomatic throughout all of these months. 318 contacts have been identified for this patient with contact investigations initiated on all contacts. To date, two active disease cases have been identified who were a cellmates of the index case at two of the county jails in 2002. In addition, 48 TB infections have been identified through this contact investigation. These infections represent 15% of those investigated as contacts to the source case. These activities have led to a significant increase in dialog and protocol review with the state prison system and many local jails.
Kansas Childhood Lead Poisoning Prevention Program
Based on the November 1997 Centers for Disease Control and Prevention (CDC) guidelines (Screening Young Children for Lead Poisoning: Guidance for State and Local Public Health Officials), the Kansas Childhood Lead Poisoning Prevention Program (KCLPPP) developed and the Kansas Lead Council approved the universal Kansas Blood Lead Testing Plan. The Kansas Blood Lead Testing Plan has been distributed to over 1,200 healthcare providers across Kansas.
The Kansas case management plan was developed and implemented in 2002. Case Management of the Lead Poisoned Child was introduced during workshops in Kansas’ communities. Explanation and demonstration of the care plan to healthcare providers and local health department staff was presented through these workshops. Legislative action was taken in regard to reporting of blood lead levels. Kansas Administrative Regulation (K.A.R.) 28-1-18 was amended December 2, 2002, to require laboratories to report all blood lead levels to KDHE. Data received is entered into the STELLAR (Systematic Tracking of Elevated Lead Levels and Remediation) surveillance system. As of December 2002, 85% of the reporting laboratories are sending all test results to KCLPPP via electronic transmission and mailed hard copies. KCLPPP Website: (different from last year) – www.unleadedks.com
SECTION I - DISEASE SUMMARIES
ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) and HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION
AIDS is a severe, life-threatening condition first recognized as a distinct syndrome in 1981. This syndrome is caused by the human immunodeficiency virus (HIV), a pathogen that damages the body's immune system. With a weakened immune system, other pathogens may easily invade the body, allowing opportunistic diseases to develop and cause death. Most people infected with HIV develop detectable antibodies within 1-3 months after infection, but may remain free of signs or symptoms for several months to years. Clinical illness may include lymphadenopathy, chronic diarrhea, weight loss, fever, and fatigue. The severity of HIV-related illness is, in general, directly related to the degree of immune dysfunction. The virus can be transmitted from person to person through unprotected sexual contact, sharing HIV-contaminated needles and syringes, from mother to infant, and transfusion of infected blood or its components. No vaccine exists for HIV infection, but considerable progress has been made in the development of anti- retro viral therapies, which slow viral progression and significantly reduce the amount of virus in an infected person.
HIV infection and AIDS are reportable in Kansas. A person previously reported as HIV infected is reported again as an AIDS case if an AIDS diagnosis is made.
Laboratory Criteria for Surveillance Purposes
AIDS